242 related articles for article (PubMed ID: 11799370)
1. Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.
Brockow K; Akin C; Huber M; Scott LM; Schwartz LB; Metcalfe DD
J Allergy Clin Immunol; 2002 Jan; 109(1):82-8. PubMed ID: 11799370
[TBL] [Abstract][Full Text] [Related]
2. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
7. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
[TBL] [Abstract][Full Text] [Related]
8. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353
[TBL] [Abstract][Full Text] [Related]
10. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
11. Microdialysis of histamine in the skin of patients with mastocytosis.
Krogstad AL; Roupe G
Exp Dermatol; 2001 Apr; 10(2):118-23. PubMed ID: 11260250
[TBL] [Abstract][Full Text] [Related]
12. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.
Wimazal F; Jordan JH; Sperr WR; Chott A; Dabbass S; Lechner K; Horny HP; Valent P
Am J Pathol; 2002 May; 160(5):1639-45. PubMed ID: 12000716
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma.
Fukushima N; Satoh T; Sano M; Tokunaga O
Leuk Lymphoma; 2001 Aug; 42(4):709-20. PubMed ID: 11697501
[TBL] [Abstract][Full Text] [Related]
14. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
15. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase.
Steinhoff M; Corvera CU; Thoma MS; Kong W; McAlpine BE; Caughey GH; Ansel JC; Bunnett NW
Exp Dermatol; 1999 Aug; 8(4):282-94. PubMed ID: 10439226
[TBL] [Abstract][Full Text] [Related]
17. Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1.
Huygen FJ; Ramdhani N; van Toorenenbergen A; Klein J; Zijlstra FJ
Immunol Lett; 2004 Feb; 91(2-3):147-54. PubMed ID: 15019283
[TBL] [Abstract][Full Text] [Related]
18. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
[TBL] [Abstract][Full Text] [Related]
19. No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis.
Rosell A; Karlström C; Dahlin JS; Boey D; Klimkowska M; Ax K; Thålin C; Ungerstedt J
Scand J Immunol; 2024 Jan; 99(1):e13333. PubMed ID: 38112220
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and transcriptomic screening demonstrates increased mast cell-derived CCL23 in systemic mastocytosis.
Söderlund S; Boey D; van Midden W; Kjellander M; Ax K; Qian H; Dahlin JS; Ungerstedt J
J Allergy Clin Immunol; 2023 Jul; 152(1):205-213. PubMed ID: 36813186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
